Ironwood Pharmaceuticals Statistics
Total Valuation
IRWD has a market cap or net worth of $799.61 million. The enterprise value is $1.05 billion.
| Market Cap | 799.61M |
| Enterprise Value | 1.05B |
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IRWD has 165.55 million shares outstanding. The number of shares has decreased by -5.74% in one year.
| Current Share Class | 165.55M |
| Shares Outstanding | 165.55M |
| Shares Change (YoY) | -5.74% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 3.23% |
| Owned by Institutions (%) | 82.11% |
| Float | 137.08M |
Valuation Ratios
The trailing PE ratio is 5.33 and the forward PE ratio is 3.44.
| PE Ratio | 5.33 |
| Forward PE | 3.44 |
| PS Ratio | 2.00 |
| Forward PS | 1.67 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.89 |
| P/OCF Ratio | 3.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.14, with an EV/FCF ratio of 5.11.
| EV / Earnings | 7.01 |
| EV / Sales | 2.62 |
| EV / EBITDA | 4.14 |
| EV / EBIT | 4.17 |
| EV / FCF | 5.11 |
Financial Position
The company has a current ratio of 6.51
| Current Ratio | 6.51 |
| Quick Ratio | 6.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | 1.31 |
| Debt / FCF | 1.64 |
| Interest Coverage | 8.82 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 45.82% |
| Return on Invested Capital (ROIC) | 65.32% |
| Return on Capital Employed (ROCE) | 98.38% |
| Weighted Average Cost of Capital (WACC) | 5.58% |
| Revenue Per Employee | $4.00M |
| Profits Per Employee | $1.50M |
| Employee Count | 100 |
| Asset Turnover | 1.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IRWD has paid $77.33 million in taxes.
| Income Tax | 77.33M |
| Effective Tax Rate | 34.07% |
Stock Price Statistics
The stock price has increased by +55.31% in the last 52 weeks. The beta is 0.24, so IRWD's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +55.31% |
| 50-Day Moving Average | 3.97 |
| 200-Day Moving Average | 3.95 |
| Relative Strength Index (RSI) | 74.92 |
| Average Volume (20 Days) | 2,403,651 |
Short Selling Information
The latest short interest is 15.89 million, so 9.60% of the outstanding shares have been sold short.
| Short Interest | 15.89M |
| Short Previous Month | 15.57M |
| Short % of Shares Out | 9.60% |
| Short % of Float | 11.59% |
| Short Ratio (days to cover) | 7.16 |
Income Statement
In the last 12 months, IRWD had revenue of $400.30 million and earned $149.63 million in profits. Earnings per share was $0.91.
| Revenue | 400.30M |
| Gross Profit | 305.72M |
| Operating Income | 251.72M |
| Pretax Income | 226.95M |
| Net Income | 149.63M |
| EBITDA | 253.54M |
| EBIT | 251.72M |
| Earnings Per Share (EPS) | $0.91 |
Balance Sheet
The company has $86.38 million in cash and $336.21 million in debt, with a net cash position of -$249.83 million or -$1.51 per share.
| Cash & Cash Equivalents | 86.38M |
| Total Debt | 336.21M |
| Net Cash | -249.83M |
| Net Cash Per Share | -$1.51 |
| Equity (Book Value) | -97.19M |
| Book Value Per Share | -0.59 |
| Working Capital | 191.26M |
Cash Flow
In the last 12 months, operating cash flow was $205.37 million and capital expenditures $1,000, giving a free cash flow of $205.37 million.
| Operating Cash Flow | 205.37M |
| Capital Expenditures | 1,000 |
| Depreciation & Amortization | 1.82M |
| Net Borrowing | -260.00M |
| Free Cash Flow | 205.37M |
| FCF Per Share | $1.24 |
Margins
Gross margin is 76.37%, with operating and profit margins of 62.88% and 37.38%.
| Gross Margin | 76.37% |
| Operating Margin | 62.88% |
| Pretax Margin | 56.70% |
| Profit Margin | 37.38% |
| EBITDA Margin | 63.34% |
| EBIT Margin | 62.88% |
| FCF Margin | 51.31% |
Dividends & Yields
IRWD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 5.74% |
| Shareholder Yield | 5.74% |
| Earnings Yield | 18.77% |
| FCF Yield | 25.68% |
Analyst Forecast
The average price target for IRWD is $6.18, which is 27.85% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.18 |
| Price Target Difference | 27.85% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 19.11% |
| EPS Growth Forecast (3Y) | 83.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRWD has an Altman Z-Score of -1.37 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.37 |
| Piotroski F-Score | 8 |